06
Top Firms
05
Top 20 Organizations Clinical Vacancies, Life Sciences Sector, Europe, 2021-2023*
Whilst the ongoing importance of the CROs in terms of the clinical function is clear, when analyzing activity by organization, it is not a surprise these are the businesses with some of the biggest drops in vacancies, year on year. Nonetheless, of the top five companies with clinical vacancies this year, four are CROs. With that, ones worth profiling include: • Syneos Health, which although it has had the highest annual totals is set to see a 42.6% year-on-year reduction in vacancies. • AstraZeneca is the leading Pharmaceutical company in terms of Clinical vacancies and has actually had a significant uplift in activity this year, with volumes up 45.7%. • PRA has had the steepest year-on-year decline in activity, with vacancies down 54% on last year. • In contrast, Pfizer is one to watch, with a year-on-year uplift of 127%, which is the largest increase out of any of the organizations in the top 20. • Novartis have also had a significant surge in activity this year, with vacancies up 78% on 2022. • Within the top ten organizations, Merck has seen the biggest increase, with vacancies up 66% on last year. In summary, eleven of the top twenty organisations have seen a decline in clinical vacancies, equally when we remove the CROs from that, we see that it is only six out of fifteen. Put another way, 60% of the pharmaceutical companies have seen an uplift this year compared to last which suggests that as the number of trials has slowed down, they have just decided to do more in-house and outsource less. Equally given what we discussed earlier, in terms of the regulators getting up to date with their backlogs of trial requests, we expect next year to be a busy one all round.
YoY%
Organization
2021 2022 2023*
-42.6%
Syneos Health
1528
1854
3230
-9.8%
Iqvia
1239
832
922
45.7%
AstraZeneca
524
397
360
-54.1%
PRA Health Sciences
422
1130
920
-44.4%
ICON
396
625
712
Parexel Labcorp Drug Development Novo Nordisk
-4.1%
367
617
383
-38.7%
322
798
525
16.0%
311
210
268
Merck
66.4%
228
121
137
GSK
-9.9%
181
207
201
Medpace
1.1%
154
121
152
Lilly
41.9%
88
132
93
Cromsource
-7.8%
124
161
134
Novartis
78.2%
118
86
66
-19.4%
Cmed
23
108
134
127.0%
Pfizer
104
87
46
-67.8%
Johnson & Johnson
198
67
209
22.8%
129
53
43
AbbVie
-49.0%
90
41
80
Roche
-64.5%
35
151
98
Bristol-Myers Squibb
Source: Vacancysoft Analytics
Fig. 07
2023* - Estimation
Made with FlippingBook - professional solution for displaying marketing and sales documents online